Where he was treated: Brantly was flown to Dobbins Air Reserve Base in Georgia on August 2 and was taken by ambulance to Emory University Hospital in Atlanta.
Treatment given: Brantly received one of the first doses of ZMapp, an experimental drug that had never been tested in humans. ZMapp was developed by the biotech firm Mapp Biopharmaceutical Inc., which is based in San Diego.
Current status: Brantly was released from Emory on August 21, free of the virus.